Xarelto (rivaroxaban)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS AND PRECAUTIONS Risk of Bleeding Addition of selective serotonin reuptake inhibitors, and serotonin...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts